Thanks to all our sponsors and partners who help make the ASPET annual meeting at Experimental Biology a success. Please support our sponsors by visiting them from the links below.
If you would like to become a sponsor, check out our Become a Sponsor page.
The objective of the NIH T32-supported Molecular and Cellular Pharmacology (MCP) Training Program is to equip students with the skills required to conduct high impact biomolecular, biomedical,
and pharmacological basic research. The program assists students in becoming independent investigators in these research areas, facilitating their entry into careers in industry, academia, and beyond. Advances in biomedical sciences are often based
on the development of new drugs, which improve and save the lives of millions of patients. Drugs with specific biochemical actions are also powerful research tools. They provide pharmacologists and other biomedical scientists unique research opportunities,
which help to elucidate cellular signaling cascades. Students in the MCP program will develop expertise in the fundamentals of Molecular and Cellular Pharmacology and solve a variety of problems in the basic biomedical sciences involving the design
of research strategies for the discovery of novel drugs or gene therapy approaches.
Pharmacology at the University of Michigan has a 125-year history of healing through discovery. More than any other basic science discipline, pharmacology is tightly connected to the understanding and treatment of human disease. At U-M, trainees can be
involved in the discovery of new drugs, modeling of drugs and their targets, detailed studies of drug mechanisms in disease from biochemical, molecular, and genetic perspectives, and translational studies aimed at moving drugs into the clinic. Our
trainees have gone on to become pharmaceutical company executives, research directors, and senior scientists, directors of government research labs, and recognized chairs and faculty in academia. Explore the many training opportunities we offer, including
summer internships, masters and doctoral programs, and postdoctoral fellowships.
Pharmacology and Therapeutics Discovery (PTD) is multidisciplinary training area in the PhD Program in Biomedical Sciences at Icahn School of Medicine at Mount Sinai, in New York, NY. The PTD program provides cutting-edge training in a range of disciplines,
integrating experimental and computational methodologies, for the discovery of new therapeutics and the development of personalized medicine. Trainees gain a thorough understanding of drugs and drug targets, using a variety of approaches ranging from
structural, computational, molecular, and cell biology to biochemistry and synthetic chemistry. Our students also gain a deep understanding of biological systems and disease states through training that emphasizes a quantitative, predictive understanding
of physiology, pharmacology, organ-level research, and animal studies. PTD welcomes students with biological sciences background as well as those with undergraduate degrees in more quantitative disciplines. Our program promotes innovation through
coursework in entrepreneurship and summer internships with biotechnology and pharmaceutical companies.
Physiology and Pharmacology is a discipline within the Integrated Biomedical Sciences Graduate Program at the Graduate School of Biomedical Sciences at UT Health San Antonio.
The Physiology and Pharmacology Discipline encompasses the study of fundamental mechanisms of normal and disease function. Investigators seek to integrate information from molecular, cellular and organ/system levels to spur discoveries, and improve
treatments for disease. Using sophisticated genetic and molecular tools, as well as a wide range of behavioral approaches, our scientists are unraveling the fundamental mechanisms that underlie tissue and cellular physiology, and how these processes
are compromised in injury and disease.
UT Health San Antonio is renowned for its seminal contributions in many areas including cardiovascular physiology, neuropharmacology, neurophysiology, and the physiological basis of aging. Internationally recognized research expertise is assembled
in areas of neuropharmacology, addiction and pain research, diabetes and cardiovascular disease, neurodegenerative disease, and cancer pharmacology.
Pharmacology Research & Perspectives (PR&P) is an Open Access journal addressing preclinical and clinical pharmacology, education and fundamental and
applied pharmacology, including articles that disprove a hypothesis. It is a leading outlet for drug discovery and development programs.
PR&P is a great place to publish:
- Official journal of two of the world's leading pharmacology societies: The British Pharmacological Society and the American Society for Pharmacology and Experimental Therapeutics
- Open access - Your research is immediately available to all, giving it maximum accessibility and visibility
- Global readership - doubling every year.
- About to get Impact Factor (already Indexed by Scopus, Medline and ESCI)
- Speed of review/decision – Average time to first decision is only 26 days
- Welcome pre-submission enquiries
Our subject coverage is broad based and content is welcomed from academic, R&D and early career researchers.
Read and write with us today!
The Department of Pharmacology at the University of Minnesota is one of six basic science departments in the Medical School. The well-funded research programs of our primary faculty members focus on understanding and developing better treatments for cancer,
addiction and the opioid crisis, cardiovascular disease, infectious disease, and metabolic syndrome. We also offer an undergraduate Pharmacology Minor, oversee the Graduate Program in Pharmacology, teach fundamental principles of pharmacology to students
in professional degree programs (MD, DDS, MD/PhD, and JD/PhD), and provide individualized training experiences for our strong community of postdoctoral scholars. Our past trainees are now applying their skills to impactful careers in academia, medicine,
industry, government, law, and regulatory oversight. We are proud of our role in preparing the next generation of scientists for rewarding careers in the health sciences and related professions, and for the various other ways we give back to our community.
The Graduate Program in Pharmaceutical Sciences at the UK College of Pharmacy prepares students for careers in all facets of pharmaceutical development and utilization as they engage in research addressing current health care challenges. Whether your
personal passion is for advancing therapies related to substance use disorders, cancer, infectious diseases, cardiovascular pathologies, or neurological disorders, UKCOP will support you in your journey. All graduate students receive a minimum stipend
The Pharmaceutical Sciences Graduate Program provides coursework and research experience across a spectrum of basic and translational sciences that support drug discovery, delivery and development. Didactic course requirements are modest, flexible and
tailored to fit individual needs and career goals.
The majority of a Ph.D. student’s time is spent pursuing a research project under the guidance of a faculty mentor. Our students actively participate in weekly research seminars, journal clubs and laboratory meetings.
The program prioritizes supporting students in presenting their research results at national and international meetings, publishing in peer-reviewed journals and seeking prestigious fellowships and awards.
Students are mentored by world-recognized scientists across a variety of research area including autoimmune disorders, cancer biology, drug delivery/nanotechnology, drug-diet interactions, drug discovery, molecular therapies, biomedical, drug discovery,
molecular therapeutics, pharmacogenomics, toxicity, and translational pharmacology.
The Department of Pharmaceutical and Biomedical Sciences focuses on groundbreaking discoveries in multiple areas of pharmaceutical sciences. These include drug discovery, medicinal chemistry, chemical biology, structural biology, gene editing and delivery,
protein kinases, synthetic biologics, pharmaceutics, pharmacology, cell signaling and death, cancer biology, drug delivery, and toxicology, among others. Although seemingly diverse, almost all research is focused on drug discovery and therapeutics
for treating diseases. This diversity also allows for a truly interdisciplinary and integrated training experience. Graduates of our program have had successful careers in the pharmaceutical industry, healthcare, academia and government.
The MCP Program at SBU brings together gifted students, scientists, and physicians to explore fundamental mechanisms that regulate cell and organ function and therapeutic development to intervene when they are errant.
Our PhD Program composes training faculty from many Departments at Stony Brook, Brookhaven National Laboratories and Cold Spring Harbor Laboratories.
It offers comprehensive training from basic biological sciences to the study of cell, tissues and organisms. Research interests include cancer and infectious disease, cardiovascular and endocrine pharmacology, neuropharmacology and drug design. The
coursework provides training in pharmacology, genetics, cell biology, immunology, structural and computational biology, and neuropharmacology.
The MS Program provides a springboard for students pursuing careers in academic (PhD, MD, and Pharmacy), pharmaceutical, and government sectors.
The Pharmacological Sciences Department also houses the SBU Medical Scientist Training Program and the Scholars in BioMedical Sciences Advanced Graduate Certificate Program.